Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 6.43B | 11.46B | 10.54B | 10.13B | 8.56B | 6.17B |
Gross Profit | 3.04B | 5.46B | 5.05B | 4.84B | 4.21B | 2.96B |
EBITDA | 628.60M | 1.65B | 1.58B | 1.15B | 1.30B | 884.20M |
Net Income | 468.20M | 490.00M | 538.80M | 142.50M | 369.70M | 224.30M |
Balance Sheet | ||||||
Total Assets | 9.95B | 9.95B | 8.05B | 8.02B | 7.07B | 5.16B |
Cash, Cash Equivalents and Short-Term Investments | 731.00M | 731.00M | 1.15B | 1.58B | 1.31B | 964.40M |
Total Debt | 3.74B | 3.74B | 2.61B | 2.45B | 2.37B | 2.10B |
Total Liabilities | 6.58B | 6.58B | 5.18B | 5.39B | 4.73B | 3.67B |
Stockholders Equity | 2.92B | 2.92B | 2.46B | 2.12B | 1.93B | 1.24B |
Cash Flow | ||||||
Free Cash Flow | 652.60M | 713.00M | 611.30M | 735.00M | 1.02B | 938.30M |
Operating Cash Flow | 908.90M | 1.23B | 1.14B | 1.08B | 1.27B | 1.06B |
Investing Cash Flow | -448.80M | -1.49B | -543.50M | -320.90M | -848.10M | -334.70M |
Financing Cash Flow | -655.70M | -141.00M | -1.01B | -479.20M | -83.60M | -239.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | £4.50B | 9.01 | 19.64% | 1.12% | 14.60% | 58.84% | |
73 Outperform | £2.19B | 14.09 | ― | 3.79% | 3.78% | 3.44% | |
68 Neutral | £3.11B | 10.86 | 14.90% | ― | -11.05% | -24.53% | |
52 Neutral | £570.69M | -3.70 | -106.64% | ― | -20.36% | ― | |
46 Neutral | £355.65M | -1.21 | -64.97% | ― | -15.86% | -18.46% | |
38 Underperform | £158.87M | -0.47 | -8369.23% | ― | -45.91% | -120.22% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |